Archives
-
VPS13A–XKR1 Reveals a Route for Bulk Lipid Transfer
2026-10-06
A 2026 preprint combines near-atomic cryo-electron microscopy with molecular dynamics simulations to examine how VPS13A partners with the plasma-membrane scramblase XKR1. The proposed mechanism links VPS13A-mediated delivery to one membrane leaflet with XKR1-dependent lipid equilibration, offering a structural framework for bulk membrane expansion while remaining subject to validation beyond the preprint and computational models.
-
Pheromone Signaling and Neurodegeneration in C. elegans
2026-10-06
Peng et al. identify a developmental mechanism in which early exposure to the pheromones ascr#3 and ascr#10 remodels neural signaling and later accelerates neurodegeneration in adult C. elegans. The study connects chemosensory neurons, AIA interneurons, insulin-like signaling, and autophagy, while also defining important limits for applying the findings beyond this model organism.
-
SARS-CoV-2 N Protein and GADD34 Immune Evasion
2026-10-05
A 2024 Molecules study identifies an atypical stress-granule-like mechanism through which SARS-CoV-2 nucleocapsid protein suppresses GADD34 expression and weakens IRF3-dependent innate immunity. The findings connect RNA–protein compartmentalization with interferon regulation, while remaining limited to the study’s experimental systems and requiring further validation in infection-relevant models.
-
Hoechst 33342 in Sodium-Overload Necrosis Research
2026-10-05
Hoechst 33342 is a bis-benzimidazole fluorescent dye used to visualize DNA-containing structures, nuclear morphology, and chromatin. This overview explains what its signal can contribute to research on sodium-overload necrosis, while distinguishing nuclear imaging evidence from direct measurements of mitochondrial metabolism, ion balance, ATP depletion, and cell death mechanism.
-
Mouse Tissue Lysis Kit K1038 Overview
2026-10-04
K1038 is an APExBIO research-use kit described for tissue lysis and direct PCR template preparation in genotyping workflows. No matched peer-reviewed paper evidence was supplied, so performance claims remain vendor-reported and assay-specific validation is outside the available evidence.
-
GSTA1, Glutathione Loss, and α-Amanitin Hepatotoxicity
2026-10-03
A 2026 study identifies a context-dependent role for GSTA1 in α-amanitin liver injury: rather than protecting hepatocytes, elevated GSTA1 was associated with glutathione depletion and worsening oxidative stress. Using integrated animal, cellular, biochemical, multi-omics, interaction, and genetic evidence, the paper proposes the NRF2–GSTA1 axis as a mechanistic and biomarker-oriented direction for further hepatotoxicity research.
-
Necrosulfonamide: Mapping Necroptosis Causality
2026-10-01
Necrosulfonamide is a selective MLKL inhibitor for resolving how upstream stress becomes necroptotic membrane failure. This article connects the compound to peroxynitrite-driven calcium dysregulation in cardiac microvascular injury and shows how to design more discriminating necroptosis assays.
-
Phytol Workflows for RXR Assays
2026-10-01
Build more reliable Phytol studies by separating RXR-driven transcription from formulation, metabolism, viability, and GABAergic effects. This workflow combines dose–time mapping, isomer-aware controls, and orthogonal readouts to turn a multifunctional diterpene into a decision-ready research tool.
-
Asunaprevir: From Protease Mechanism to Translation
2026-09-30
A translational framework for using Asunaprevir (BMS-650032) to connect HCV NS3/4A protease inhibition with genotype-aware assay design, liver exposure hypotheses, and orthogonal validation strategies inspired by mechanistic cancer research.
-
Perospirone: From Receptors to Kv1.5 Translation
2026-09-30
Perospirone is best understood not only as a serotonin–dopamine antagonist, but also as a mechanistically informative probe for vascular ion-channel pharmacology. New Kv1.5 findings create a translational framework linking schizophrenia research, neuropsychiatric disorder models, and cardiovascular safety strategy.
-
SD 169 (indole-5-carboxamide) Assay Guide
2026-09-29
A practical, scenario-based guide to using SD 169 (indole-5-carboxamide), SKU C5850, in p38 MAPK, viability, proliferation, and apoptosis workflows. It combines formulation guidance, assay controls, data interpretation, and evidence-aware considerations for type 1 diabetes research and axonal regeneration research.
-
Monomeric Aβ–Microglia Signaling in Brain Development
2026-09-29
Kwon and colleagues identify a monomeric amyloid-β signaling pathway involving APP and Ric8a that restrains microglial immune activation during mouse neocortical development. Their findings connect disruption of this pathway with matrix proteinase activation, basement membrane degradation, neuronal ectopia, and cortical laminar defects, while also highlighting important limits in translating developmental mouse biology to Alzheimer’s disease.
-
EZ Cap™ CBEmax mRNA (m1Ψ) Assay Guide
2026-09-28
A scenario-based guide to designing viability, proliferation, and cytotoxicity readouts around EZ Cap™ CBEmax mRNA (m1Ψ), SKU R1044. It separates delivery-related stress from editing biology, outlines practical controls, and connects assay interpretation to published base-editing evidence.
-
TMRE Mitochondrial Membrane Potential in Energy Failure
2026-09-28
The TMRE mitochondrial membrane potential assay kit can reveal early changes in mitochondrial polarization, but a fluorescence shift is not a complete readout of energy failure or cell-death mechanism. This article connects TMRE interpretation to a recent study of sodium-driven mitochondrial dysfunction and outlines how to build a more informative assay.
-
Asunaprevir Workflows for HCV Protease Research
2026-09-27
Use Asunaprevir (BMS-650032) to connect direct NS3/4A protease inhibition with downstream HCV RNA replication readouts. This guide pairs a practical assay workflow with controls and troubleshooting, while clearly separating HCV evidence from a cross-disciplinary cancer-screening study.